Medicamen Biotech Ltd
₹223.30
(-6.49%)
Sat, 04 Apr 2026, 11:51 am
Health Technology
Pharmaceuticals: Major
24.5KMedicamen Biotech PE Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 7.37 | 8.28 | 6.87 | 5.81 | 4.84 | 6.82 | 0 | 0 | 106.82 | 29.53 | 115.73 | 104.94 | 65.99 | 47.18 | 16.61 | 53.78 | 52.79 | 55.01 | 44.37 | 86.16 |
| Price to book ratio | 1.29 | 1.24 | 0.90 | 0.62 | 1.18 | 0.95 | 0.55 | 0.44 | 0.63 | 0.80 | 3.10 | 20.40 | 9.34 | 6.55 | 1.82 | 4.91 | 5.37 | 4.29 | 2.34 | 2.87 |
| Price to sales ratio | 0.21 | 0.21 | 0.14 | 0.09 | 0.19 | 0.15 | 0.10 | 0.11 | 0.14 | 0.17 | 0.82 | 6.57 | 5.98 | 4.63 | 1.76 | 5.79 | 6.81 | 5.80 | 2.70 | 3.77 |
| Price to cash flow ratio | 4.24 | 48.19 | 4.58 | 1.15 | 0 | 1.96 | 0 | 0 | 4.40 | 0 | 16.99 | 854.76 | 0 | 132.31 | 17.59 | 55 | 276.51 | 0 | 0 | 0 |
| Enterprise value | 181.43M | 243.43M | 231.94M | 158.67M | 307.33M | 239.35M | 212.71M | 215.79M | 225.28M | 305.71M | 728.07M | 5.56B | 6.59B | 5.71B | 2.29B | 6.67B | 8.08B | 8.21B | 5.01B | 6.42B |
| Enterprise value to EBITDA ratio | 7.78 | 9.41 | 6.23 | 3.55 | 4.08 | 4 | 10.45 | 0 | 4.31 | 6.06 | 13.15 | 47.98 | 39.24 | 32.28 | 11.50 | 33.34 | 33.02 | 32.19 | 20.22 | 43.59 |
| Debt to equity ratio | 0.85 | 1.23 | 1.16 | 0.68 | 0.78 | 0.48 | 0.68 | 1.08 | 0.93 | 1.21 | 1.14 | 0.66 | 0.19 | 0.14 | 0.09 | 0.14 | 0.18 | 0.13 | 0.15 | 0.16 |
| Return on equity % | 0 | 16.16 | 13.95 | 11.22 | 27.21 | 15.14 | -4.07 | -27.51 | 0.58 | 2.61 | 2.74 | 23.09 | 19.95 | 14.92 | 12.79 | 9.55 | 10.67 | 8.73 | 5.46 | 3.38 |
Medicamen Biotech Ltd Price to Earnings Ratio
The Medicamen Biotech Ltd Price to Earnings Ratio is a key financial metric used by investors to evaluate Medicamen Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Medicamen Biotech Ltd Price to Earnings Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Medicamen Biotech Ltd (NSE: MEDICAMEQ, BSE: 531146) is currently trading at ₹223.30, with a market capitalization of ₹3.05B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Medicamen Biotech Ltd Price to Earnings Ratio is essential for fundamental analysis.
Medicamen Biotech Ltd Price to Earnings Ratio Current Value
The current Medicamen Biotech Ltd Price to Earnings Ratio stands at 86.16.
The latest Medicamen Biotech Ltd Price to Earnings Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Medicamen Biotech Ltd Price to Earnings Ratio Historical Trend
The Medicamen Biotech Ltd Price to Earnings Ratio has shown the following historical trend:
- 2024: 86.16
- 2023: 44.37
- 2022: 55.01
- 2021: 52.79
- 2020: 53.78
The recent rise in Medicamen Biotech Ltd Price to Earnings Ratio suggests strengthening valuation trends and improving market sentiment.
What Medicamen Biotech Ltd Price to Earnings Ratio Indicates for Investors
The Medicamen Biotech Ltd Price to Earnings Ratio plays a crucial role in understanding the company's financial health and valuation.
A higher P/E ratio indicates investors expect strong future earnings growth, while a lower ratio may signal undervaluation.
Medicamen Biotech Ltd Price to Earnings Ratio Analysis Summary
The Medicamen Biotech Ltd Price to Earnings Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Medicamen Biotech Ltd Price to Earnings Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Medicamen Biotech Ltd Price to Earnings Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800